NASDAQ:ASND

Ascendis Pharma A/s Stock Forecast

etoro logo Buy ASND
*Your capital is at risk
$228.00
-2.83 (-1.23%)
At Close: Jun 22, 2026
AI Analysis AI Analysis of ASND AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add ASND to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Ascendis Pharma A/S stock downgraded to Sell Candidate
(Updated on Jun 22, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Jun 22, 2026

The Ascendis Pharma A/S stock price fell by -1.23% on the last day (Monday, 22nd Jun 2026) from $230.83 to $228.00. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 4.28% from a day low at $227.18 to a day high of $236.90. The price has been going up and down for this period, and there has been a 8.34% gain for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -329 thousand shares and in total, 557 thousand shares were bought and sold for approximately $127.02 million.

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -2.06% during the next 3 months and, with a 90% probability hold a price between $200.84 and $240.86 at the end of this 3-month period.

ASND Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Ascendis Pharma A/S stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $229.66. On a fall, the stock will find some support from the short-term average at $225.45. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Tuesday, June 16, 2026, and so far it has fallen -1.38%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Ascendis Pharma A/S stock

Ascendis Pharma A/S finds support from accumulated volume at $224.11 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $9.72 between high and low, or 4.28%. For the last week, the stock has had daily average volatility of 3.71%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ASND) For The Upcoming Trading Day Of Tuesday 23rd

For the upcoming trading day on Tuesday, 23rd we expect Ascendis Pharma A/S to open at $230.69, and during the day (based on 14 day Average True Range), to move between $223.58 and $232.42, which gives a possible trading interval of +/-$8.84 (+/-3.95%) up or down from last closing price. If Ascendis Pharma A/S takes out the full calculated possible swing range there will be an estimated 3.95% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $231.05 (1.34%) than the support at $224.11 (1.71%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Ascendis Pharma A/S stock A Buy?

Ascendis Pharma A/S holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

Current score: -2.105 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on June 23, 2026 - $230.69 ( 1.18%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

ASND Performance

Trading levels for ASND

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 240.41 5.44%
R2 236.70 3.82%
R1 234.41 2.81%
Price 228.00
S1 226.98 -0.447%
S2 224.69 -1.45%
S3 220.97 -3.08%

Accumulated Volume Support & Resistance Levels

Level Price
R3 246.14 7.96%
R2 241.71 6.01%
R1 231.05 1.34%
Price 228.00
S1 224.11 -1.71%
S2 222.00 -2.63%
S3 220.28 -3.39%

FAQ

What is the symbol for Ascendis Pharma A/S Stock and on which exchange is it traded?
The symbol for Ascendis Pharma A/S is ASND and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Ascendis Pharma A/S Stock?
Ascendis Pharma A/S holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

How to buy Ascendis Pharma A/S Stock?
Ascendis Pharma A/S Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Ascendis Pharma A/S Stock.

What's the current price of Ascendis Pharma A/S Stock?
As of the end of day on the Jun 22, 2026, the price of an Ascendis Pharma A/S (ASND) share was $228.00.

What is the 52-week high and low for Ascendis Pharma A/S Stock?
The 52-week high for Ascendis Pharma A/S Stock is $250.74 and the 52-week low is $161.09.

What is the market capitalization of Ascendis Pharma A/S Stock?
As of the Jun 22, 2026, the market capitalization of Ascendis Pharma A/S is 14.161B.

When is the next earnings date for Ascendis Pharma A/S?
The upcoming earnings date for Ascendis Pharma A/S is Aug 06, 2026.
Click to get the best stock tips daily for free!
ABOUT ASCENDIS PHARMA A/S
Ascendis Pharma A/S
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops Tra...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.29% Jun 10
PHM
$118.49
6.02% Jun 10
EAT
$140.46
17.09% Jun 05
E
ETD
$20.67
3.19% Jun 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE